Scientist
Bio-Techne
Justin Janovsky is a Scientist specializing in the development of molecular research and diagnostic assays. He earned three bachelor's degrees from the University of Texas in chemistry, biochemistry, and cell and molecular biology and has worked two years in academia and ten years in the biotech industry. As an R&D scientist, he has developed expertise in qPCR, capillary electrophoresis, and long-read sequencing. His career has focused heavily on the assay development pipeline, and to that end he performs laboratory testing and analysis of optimization, guard-banding, validation, and equivalency experiments. As an employee at Asuragen and then Bio-Techne following acquisition of Asuragen, he has worked to develop a PCR/CE diagnostic for SMA that discerns the SMN1 gene from the SMN2 gene and quantifies the number of copies of each. Most recently, he has worked on development and support of a long-read sequencing-based carrier screening assay for the detection of pathogenic variants across eleven genes responsible for some of the most common hereditary disorders, including cystic fibrosis, spinal muscular atrophy, fragile X syndrome, certain hemoglobinopathies, and others.